A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients
Clinical trial NCT05815901 · COMPLETED
Trial details
- NCT number
- NCT05815901
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2024-03-26
- Enrollment
- 612
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.